Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$16.98 - $25.54 $194,845 - $293,071
-11,475 Reduced 44.19%
14,492 $272,000
Q2 2022

Aug 11, 2022

SELL
$13.15 - $20.45 $21,566 - $33,538
-1,640 Reduced 5.94%
25,967 $484,000
Q1 2022

Apr 29, 2022

BUY
$14.54 - $21.5 $109,457 - $161,852
7,528 Added 37.49%
27,607 $499,000
Q4 2021

Feb 04, 2022

BUY
$20.24 - $36.01 $24,713 - $43,968
1,221 Added 6.47%
20,079 $416,000
Q3 2021

Oct 14, 2021

BUY
$26.01 - $38.22 $22,966 - $33,748
883 Added 4.91%
18,858 $604,000
Q2 2021

Aug 06, 2021

SELL
$29.97 - $37.17 $234,964 - $291,412
-7,840 Reduced 30.37%
17,975 $554,000
Q1 2021

May 13, 2021

BUY
$29.24 - $42.03 $269,358 - $387,180
9,212 Added 55.48%
25,815 $870,000
Q4 2020

Mar 02, 2021

BUY
$35.35 - $50.67 $259,610 - $372,120
7,344 Added 79.32%
16,603 $600,000
Q3 2020

Nov 18, 2020

BUY
$35.98 - $47.66 $35,404 - $46,897
984 Added 11.89%
9,259 $341,000
Q2 2020

Aug 14, 2020

BUY
$45.06 - $67.74 $44,609 - $67,062
990 Added 13.59%
8,275 $337,000
Q1 2020

May 18, 2020

BUY
$40.01 - $73.97 $23,445 - $43,346
586 Added 8.75%
7,285 $412,000
Q4 2019

Feb 13, 2020

BUY
$37.13 - $74.62 $244,092 - $490,551
6,574 Added 5259.2%
6,699 $415,000
Q4 2019

Feb 12, 2020

BUY
$37.13 - $74.62 $4,641 - $9,327
125 New
125 $472,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $300M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Capital Asset Advisory Services LLC Portfolio

Follow Capital Asset Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Asset Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Asset Advisory Services LLC with notifications on news.